KPV — 10mg
Product Overview
KPV is the C-terminal tripeptide sequence lysine-proline-valine derived from alpha-melanocyte-stimulating hormone.
Research Background
KPV has been examined in cellular and animal models involving inflammatory signalling. Published experiments have explored NF-kappa-B-related pathways, epithelial transport and mechanisms that may be partly independent of classical melanocortin receptors.
Current Areas of Investigation
Research applications include epithelial-cell signalling, cytokine-response models, peptide transport and comparisons between full-length melanocortins and shorter peptide fragments.
In Plain Language
Researchers are exploring how KPV may affect inflammatory messages inside cells, especially pathways involving NF-kappa-B and the response of epithelial barriers to stress. Studies have examined cytokine release, immune-cell movement and transport of the small tripeptide across epithelial cells.
In plain terms, KPV research asks whether a very short fragment of alpha-MSH can help quiet excessive inflammatory signalling without requiring all of the parent hormone’s receptor activity. Intestinal, skin and airway models are among the areas being investigated.
Product Specifications
- Catalogue No.: KPV5
- Vial Size: 10mg
Quality & Documentation
Lot-specific product documentation and Certificate of Analysis (COA) information may be available through AURAPEP where applicable.
Research Use Only
RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION. Supplied strictly for laboratory, analytical and research purposes. Not intended for self-administration or to diagnose, treat, cure or prevent any disease.
